ArrowMark Colorado Holdings’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.62M | Buy |
293,006
+57,812
| +25% | +$1.5M | 0.14% | 156 |
|
|
2025
Q1 | $5.76M | Buy |
235,194
+10,612
| +5% | +$260K | 0.09% | 166 |
|
|
2024
Q4 | $6.44M | Sell |
224,582
-5,808
| -3% | -$167K | 0.09% | 172 |
|
|
2024
Q3 | $8.69M | Buy |
230,390
+34,131
| +17% | +$1.29M | 0.11% | 150 |
|
|
2024
Q2 | $6.2M | Buy |
196,259
+152
| +0.1% | +$4.8K | 0.07% | 183 |
|
|
2024
Q1 | $8.61M | Buy |
+196,107
| New | +$8.61M | 0.1% | 164 |
|